Drugs / Bovine Colostrum
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT06164600 | Jun 2023 → Aug 2024 | urinary tract infection | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT03281655 | Dec 2016 → May 2017 | postmenopausal atrophic vaginitis | University of Messina | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02473341 | Nov 2017 → Aug 2024 overdue | alcoholic hepatitis | Dayanand Medical College and Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bovine colostrum | “Dietary Supplement: Bovine colostrum” NCT06164600 ↗ |
| Modality | Protein / enzyme biologic | “safe, enterally delivered biologic” NCT02473341 ↗ |
| Route | Oral | “adding oral IgG-enriched bovine colostrum to standard medical treatment” NCT02473341 ↗ |